1921
Volume 102, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.20-0246
2020-04-09
2020-07-09
Loading full text...

Full text loading...

/deliver/fulltext/14761645/102/6/tpmd200246.html?itemId=/content/journals/10.4269/ajtmh.20-0246&mimeType=html&fmt=ahah

References

  1. Gao J, Tian Z, Yang X, 2020. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14: 7273.
    [Google Scholar]
  2. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H, 2020. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A 117: 67716776.
    [Google Scholar]
  3. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211: 8090.
    [Google Scholar]
  4. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W, 2020. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol 38: 1018.
    [Google Scholar]
  5. Casadevall A, Pirofski LA, 2020. The convalescent sera option for containing COVID-19. J Clin Invest 130: 15451548.
    [Google Scholar]
  6. Young MK, Nimmo GR, Cripps AW, Jones MA, 2014. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst Rev 1(4): CD010056.
    [Google Scholar]
  7. Janeway CA, 1945. Use of concentrated human serum gamma-globulin in the prevention and attenuation of measles. Bull N Y Acad Med 21: 202222.
    [Google Scholar]
  8. Rinaldo CR, Jr., 2005. Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951–1953. Am J Public Health 95: 790799.
    [Google Scholar]
  9. Krugman S, Ward R, 1961. Infectious hepatitis: current status of prevention with gamma globulin. Yale J Biol Med 34: 329339.
    [Google Scholar]
  10. Smetana HF, Smetana FG, 1976. Viral hepatitis in United States soldiers stationed in Korea, 1967–1970: prophylactic efficacy of gamma globulin. Bull N Y Acad Med 52: 535560.
    [Google Scholar]
  11. Wan Y et al., 2020. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol 94: e02015-19.
    [Google Scholar]
  12. Sabin AB, Schlesinger RW, 1945. Production of immunity to dengue with virus modified by propagation in mice. Science 101: 640642.
    [Google Scholar]
  13. Kirkpatrick BD et al., 2016. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci Transl Med 8: 330ra36.
    [Google Scholar]
  14. Matuschewski K, Borrmann S, 2019. Controlled human malaria infection (CHMI) studies: over 100 years of experience with parasite injections. Methods Mol Biol 2013: 91101.
    [Google Scholar]
  15. Eyal N, Lipsitch M, Smith PG, 2020. Human challenge studies to accelerate coronavirus vaccine licensure. J Infect Dis Mar 31. pii: jiaa152. doi: 10.1093.
    [Google Scholar]
  16. Harcourt J et al., 2020. Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States. Emerg Infect Dis Mar 11; 26(6). doi: 10.3201.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.20-0246
Loading
  • Received : 03 Apr 2020
  • Accepted : 05 Apr 2020
  • Published online : 09 Apr 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error